Hormone therapy modulates ETA mRNA expression in the aorta of ovariectomised New Zealand White rabbits

Gynecological Endocrinology

Volumn 25, Issue 3, 2009, Pages 175-182

  Pedersen, Susan Helene ^a,d   Nielsen, Lars Bo ^a   Pedersen, Nina Gros ^b   Nilas, Lisbeth ^c   Ottesen, Bent ^b  

^a Mental Health Services CPH   (Denmark)

^b Rigshospitalet   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d NONE   (Denmark)

Author keywords

Endothelin 1; Gene expression; Hormone therapy; New Zealand White rabbit; Progestins

Indexed keywords

CONJUGATED ESTROGEN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN CONVERTING ENZYME; ESTRADIOL; MEDROXYPROGESTERONE ACETATE; MESSENGER RNA; NORETHISTERONE ACETATE; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY WALL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; DRUG EFFECT; FEMALE; HORMONAL THERAPY; MYOGRAPHY; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; THORACIC AORTA; VASCULARIZATION;

ANIMALS; AORTA; DRUG COMBINATIONS; ENDOTHELIN-1; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; GENE EXPRESSION REGULATION; NORETHINDRONE; OVARIECTOMY; RABBITS; RNA, MESSENGER;

EID: 67651210560     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590802549833     Document Type: Article

References (40)

1. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280(7):605-613.
2. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002;288(3):321-333.
3. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 291(14):1701-1712.
4. Clarkson TB. Progestogens and cardiovascular disease. A critical review. J Reprod Med 1999;44(2 Suppl):180-184.
5. Koh KK, Sakuma I. Should progestins be blamed for the failure of hormone replacement therapy to reduce cardiovascular events in randomized controlled trials? Arterioscler Thromb Vasc Biol 2004;24(7):1171-1179.
6. Schiffrin EL. Role of endothelin-1 in hypertension and vascular disease. Am J Hypertens 2001;14(6 Pt 2):83S-89S.
7. Ylikorkala O, Orpana A, Puolakka J, Pyorala T, Viinikka L. Postmenopausal hormonal replacement decreases plasma levels of endothelin-1. J Clin Endocrinol Metab 1995; 80(11):3384-3387.
8. Webb CM, Ghatei MA, McNeill JG, Collins P. 17beta-estradiol decreases endothelin-1 levels in the coronary circulation of postmenopausal women with coronary artery disease. Circulation 2000;102(14):1617-1622.
9. Saitta A, Altavilla D, Cucinotta D, Morabito N, Frisina N, Corrado F, D'Anna R, Lasco A, Squadrito G, Gaudio A, et al. Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women. Arterioscler Thromb Vasc Biol 2001;21(9):1512-1519.
10. Akishita M, Ouchi Y, Miyoshi H, Orimo A, Kozaki K, Eto M, Ishikawa M, Kim S, Toba K, Orimo H. Estrogen inhibits endothelin-1 production and c-fos gene expression in rat aorta. Atherosclerosis 1996;125(1):27-38.
11. Tan Z, Wang TH, Yang D, Fu XD, Pan JY. Mechanisms of 17[beta]-estradiol on the production of ET-1 in ovariectomized rats. Life Sciences 2003;73(21):2665-2674.
12. Lamping KG, Nuno DW. Effects of 17 beta-estradiol on coronary microvascular responses to endothelin-1. Am J Physiol 1996;271(3 Pt 2):H1117-H1124.
13. Sudhir K, Ko E, Zellner C, Wong HE, Hutchison SJ, Chou TM, Chatterjee K. Physiological concentrations of estradiol attenuate endothelin 1-induced coronary vasoconstriction in vivo. Circulation 1997;96(10):3626-3632.
14. Winkles JA, Alberts GF, Brogi E, Libby P. Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries. Biochem Biophys Res Commun 1993;191(3):1081-1088.
15. Seo B, Oemar BS, Siebenmann R, von Segesser L, Luscher TF. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 1994; 89(3):1203-1208.
16. de Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988;85(24):9797- 9800.
17. Sitruk-Ware R. Progestins and cardiovascular risk markers. Steroids 2000;65(10-11):651-658.
18. Haarbo J, Christiansen C. The impact of female sex hormones on secondary prevention of atherosclerosis in ovariectomized cholesterol-fed rabbits. Atherosclerosis 1996;123(1-2):139-144.
19. Svensson LO, Johnson SH, Olsson SE. Plasma concentrations of medroxyprogesterone acetate, estradiol and estrone following oral administration of Klimaxil, Trisequence/Provera and Divina. A randomized, single-blind, triple cross-over bioavail-ability study in menopausal women. Maturitas 1994;18(3): 229-238.
20. Lewis LK, Elder PA, Barrell GK. An ezyme linked immunosorbent assay (ELISA) for plasma medroxyprogesterone acetate (MPA). J Steroid Biochem Molec Biol 1992; 42(2):179-183.
21. Alexandersen P, Haarbo J, Sandholdt I, Shalmi M, Lawaetz H, Christiansen C. Norethindrone acetate enhances the antiatherogenic effect of 17beta-estradiol: a secondary prevention study of aortic atherosclerosis in ovariectomized cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 1998; 18(6):902-907.
22. Dalsgaard T, Larsen CR, Mortensen A, Larsen JJ, Ottesen B. New animal model for the study of postmenopausal coronary and cerebral artery function: the Watanabe heritable hyperlipidemic rabbit fed on a diet avoiding phytoestrogens. Climacteric 2002;5(2):178-189.
23. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977;41(1):19-26.
24. Haarbo J. Hormone replacement therapy and cardiovascular disease: the rabbit model. Br J Obstet Gynaecol 1996; 103(Suppl 13):49-52.
25. Wang TH, Tan Z, Liu PQ, Lu W, Yang D, Pan JY. [Down-regulation of ETA receptor of vascular smooth muscle cells by 17 beta-estradiol]. Sheng Li Xue Bao (Acta Physiologica Sinica) 2001;53(5):380-384.
26. Telemaque-Potts S, Kuc RE, Maguire JJ, Ohlstein E, Yanagisawa M, Davenport AP. Elevated systemic levels of endothelin-1 and blood pressure correlate with blunted constrictor responses and downregulation of endothelin(A), but not endothelin(B), receptors in an animal model of hypertension. Clin Sci (Lond) 2002;103(Suppl 48):357S-362S.
27. Pedersen NG, Pedersen SH, Dalsgaard T, Lund CO, Nilas L, Ottesen B. Progestins used in hormonal replacement therapy display different effects in coronary arteries from New Zealand white rabbits. Maturitas 2004;49(4):304-314.
28. Pedersen SH, Pedersen NG, Dalsgaard T, Lund CO, Nilas L, Ottesen B. Different cerebrovascular effects of medroxypro-gesterone acetate and norethisterone acetate in the New Zealand White rabbit. Climacteric 2004;7(1):12-22.
29. Pedersen SH, Nielsen LB, Mortensen A, Sheykhzade M, Nilas L, Ottesen B. Medroxyprogesterone acetate attenuates long-term effects of 17beta-estradiol in coronary arteries from hyperlipidemic rabbits. Steroids 2006;71(9):834-842.
30. Pedersen SH, Nielsen LB, Mortensen A, Nilas L, Ottesen B. Progestins oppose the effects of estradiol on the endothelin-1 receptor type B in coronary arteries from ovariectomized hyperlipidemic rabbits. Menopause - J North Am Menopause Soc 2008. Menopause 2008;15(3):503-510.
31. David FL, Montezano AC, Reboucas NA, Nigro D, Fortes ZB, Carvalho MH, Tostes RC. Gender differences in vascular expression of endothelin and ET(A)/ET(B) receptors, but not in calcium handling mechanisms, in deoxycorticosterone acetate-salt hypertension. Braz J Med Biol Res 2002;35(9): 1061-1068.
32. David FL, Carvalho MH, Cobra AL, Nigro D, Fortes ZB, Reboucas NA, Tostes RC. Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats. Hypertension 2001;38(3 Pt 2):692-696.
33. Akishita M, Kozaki K, Eto M, Yoshizumi M, Ishikawa M, Toba K, Orimo H, Ouchi Y. Estrogen attenuates endothelin-1 production by bovine endothelial cells via estrogen receptor. Biochem Biophys Res Commun 1998;251(1):17-21.
34. Rodrigo MC, Martin DS, Eyster KM. Vascular ECE-1 mRNA expression decreases in response to estrogens. Life Sci 2003;73(23):2973-2983.
35. Gray GA, Mickley EJ, Webb DJ, McEwan PE. Localization and function of ET-1 and ET receptors in small arteries post-myocardial infarction: upregulation of smooth muscle ET(B) receptors that modulate contraction. Br J Pharmacol 2000;130(8):1735-1744.
36. Hong HJ, Liu JC, Chan P, Juan SH, Loh SH, Lin JG, Cheng TH. 17beta-estradiol downregulates angiotensin-II-induced endothelin-1 gene expression in rat aortic smooth muscle cells. J Biomed Sci 2004;11(1):27-36.
37. Smith PJW, Ornatsky O, Stewart DJ, Picard P, Dawood F, Wen WH, Liu PP, Webb DJ, Monge JC. Effects of estrogen replacement on infarct size, cardiac remodeling, and the endothelin system after myocardial infarction in ovariectomized rats. Circulation 2000;102(24):2983-2989.
38. Vikman P, Edvinsson L. Gene expression profiling in the human middle cerebral artery after cerebral ischemia. Eur J Neurol 2006;13(12):1324-1332.
39. David FL, Carvalho MH, Cobra AL, Nigro D, Fortes ZB, Reboucas NA, Tostes RC. Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats. Hypertension 2001;38(3 Pt 2):692-696.
40. Hansen VB, Skajaa K, Aalkjaer C, Oxlund H, Glavind EB, Petersen OB, Forman A. The effect of oophorectomy on mechanical properties of rabbit cerebral and coronary isolated small arteries. Am J Obstet Gynecol 1996;175(5):1272- 1280.